Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Statistical Methods in Medical Research|November 25, 2015
The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomizationLiqiong Fan, Sharon D Yeatts, Bethany J Wolf, et al.
Interventional Neurology|June 15, 2017
Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke ScaleLiqiong Fan, Sharon D Yeatts, Lydia D Foster, et al.
International Journal of Colorectal Disease|April 17, 2018
Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancerBenjamin A Kuritzkes, Emmanouil P Pappou, Ravi P Kiran, et al.
Journal of Neurosurgery|September 27, 2014
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studiesRalph Rahme, Sharon D Yeatts, Todd A Abruzzo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 25, 2018
The influence of advanced age on venous-arterial extracorporeal membrane oxygenation outcomesMichael Salna, Koji Takeda, Paul Kurlansky, et al.
Journal of Neurotrauma|February 23, 2019
Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT IIIMichael Frankel, Liqiong Fan, Sharon D Yeatts, et al.
Circulation|May 13, 2014
Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trialMayank Goyal, Mohammed A Almekhlafi, Liqiong Fan, et al.
Leukemia|April 6, 2023
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibodyMarc S Raab, Yael C Cohen, Fredrik Schjesvold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast CancerSherko Kuemmel, Mario Campone, Delphine Loirat, et al.
Pageof 1